DXR — Daxor Corporation

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Daxor Corporation

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$10.56
Market Cap$63.1M
Float2.6M
Shares Outstanding5.8M
P/E (Forward)64.52
P/E (TTM)6.60
Price/Sales (TTM)2,362.51
vs. Analyst Target+113.1% to analyst PT
Profit Margin34359.16%
Operating Margin (TTM)-9660.55%
Revenue (TTM)$26,688
Earnings Growth (YoY)329.30%
Dividend RateNone
Analyst Target Price$22.50 (2 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 -$996,299 -$1.7M -$996,299 -$1.7M
2021 $5.8M $4.7M $5.8M $4.7M
2022 $6.3M $5.2M $6.3M $5.3M
2023 $34.6M $280,640 $34.4M $329,740
2024 $2.1M $536,334 $2.1M $2.1M
2025 $503,424 $9.2M $188,741 $9.2M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2024 $71,756 -$1.6M
Dec 2024 $695,307 $2.2M
Jun 2025 $18,348 -$369,701
Dec 2025 $131,846 $9.5M

Ownership & Float

Insider Ownership49.0%
Institutional Ownership7.0%
Short Float0.1%
% of All Funds Holding0.16%
Number of Funds Holding13

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$10.21Near-term / short-term trend
Weekly40-Week SMA$12.04Medium-term trend
Weekly80-Week SMA$10.27Cyclical trend (business cycle)
Weekly200-Week SMA$9.93Secular trend (multi-year)
Monthly10-Month SMA$12.23Near-term monthly trend
Monthly20-Month SMA$10.34Medium-term monthly trend
Monthly40-Month SMA$9.76Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$12.10 resistance 1.02x 1 months ago

Historical Earnings Reactions (67 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.11% 0.00% 43.28% 8.06% -6.92%
1 Day -0.55% 0.00% 41.79% 13.96% -8.57%
1 Week 0.54% -0.30% 44.78% 38.14% -22.03%
2 Weeks -1.05% -0.28% 43.28% 31.67% -23.84%
1 Month 0.40% -1.57% 43.28% 53.12% -27.75%

Next earnings: July 10, 2024

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan4.2%53.5%43
Feb4.7%39.5%43
Mar2.2%37.2%43
Apr-1.3%39.5%43
May1.8%42.9%42
Jun3.7%54.8%42
Jul1.1%38.1%42
Aug-0.7%34.9%43
Sep0.5%32.6%43
Oct-1.1%44.2%43
Nov0.2%46.5%43
Dec-0.8%34.9%43

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.14% 32.1% 2037
Tuesday -0.05% 34.0% 2214
Wednesday 0.12% 37.4% 2211
Thursday 0.28% 37.8% 2170
Friday 0.11% 36.0% 2160

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 7.0%

Insider Transactions — Smart Summary

Total insider ownership: 49.0%

12-Month Insider Activity Summary

Total Filings6
Net Value+$18,970
Net Shares Change31,285
% of Float1.2%
C-Suite Filings6
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Michel Robert J Chief Financial Officer +$9,900 2 2 buy
Feldschuh Michael Richard Chief Executive Officer +$9,070 1 1 buy
Jefferies John Chief Medical Officer +N/A 2 2 buy
Feldschuh Jonathan Adam Chief Scientific Officer +N/A 1 1 buy

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-24 Jefferies John Chief Medical Officer +N/A N/A
2026-03-31 Michel Robert J Chief Financial Officer +$9,900 Transaction at $9.90, now +6.7%
2026-04-08 Feldschuh Michael Richard Chief Executive Officer +$9,070 Transaction at $9.07, now +16.4%
2025-12-11 Michel Robert J Chief Financial Officer +N/A N/A
2025-12-11 Feldschuh Jonathan Adam Chief Scientific Officer +N/A N/A
2025-11-14 Jefferies John Chief Medical Officer +N/A N/A

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Daxor Corporation (DXR) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for DXR on Trend Edge →